A worsening coronavirus outbreak reportedly could threaten shortages of about 150 prescription drugs, several of them with no alternatives.
China’s role in supplying the ingredients used in medications means that decreased Chinese production capability amid the outbreaks could threaten supplies of the drugs, which include antibiotics, generics, and branded drugs, two sources familiar with a Food and Drug Administration (FDA) list of at-risk drugs told Axios.
The FDA did not directly comment on the list but said it was “keenly aware that the outbreak could impact the medical product supply chain” and is working to identify potential vulnerabilities connected with it, according to Axios.